Development, Acceptability and Efficacy of a Standardized Healthy Lifestyle Intervention in Recurrent Depression
Overview
Authors
Affiliations
Background: Research evidence on the effects of integrated multifaceted lifestyle interventions for depression is scanty. The aim of the present study is to report on the development, acceptability and efficacy of a standardized healthy lifestyle intervention, including exercise, eating habits, sleep hygiene and smoking cessation in preventing relapses.
Methods: One hundred-sixty outpatients with recurrent unipolar depression or bipolar disorder were recruited after achieving full remission or recovery from the most recent depressive episode. Patients were randomized to 3-months of usual care or to an intervention aimed at promoting a healthy lifestyle (HLI), as an augmentation of pharmacological maintenance treatment. Usual care consisted of clinical management visits. At the end of the intervention, follow-up visits were scheduled at 3,6,9 and 12 months.
Results: During the intervention phase, 1 relapse occurred in the HLI group and 4 in the control group. Over the 12 months of follow-up, relapses were 5 in the HLI group and 16 in control group. Using an intent-to-treat approach, the overall percentage of relapses was 6/81 (7.4%) in the HLI group vs. 20/79 (25.3%) in the control group.. In a Kaplan-Meier survival analysis the risk of relapse was significantly lower in patients receiving the HLI intervention (log-rank test, p=0.003) over the 60 weeks of observation. The majority of patients assigned to HLI adhered to the program, and were highly motivated throughout the intervention.
Limitations: The retention rate was low because patients were recruited during the maintenance phase and the 1-year follow-up was relatively short to detect a long-term effect of HLI.
Conclusions: The HLI program proved to be efficacious in preventing relapses. Given the absence of contraindications and its cost-effectiveness in routine practice, the use of HLI should be encouraged to promote the well-being of patients with recurrent depression.
Amiri S, Mahmood N, Javaid S, Khan M Healthcare (Basel). 2024; 12(22).
PMID: 39595461 PMC: 11594078. DOI: 10.3390/healthcare12222263.
Practice Guidelines for Bipolar Disorder by the JSMD (Japanese Society of Mood Disorders).
Kato T, Ogasawara K, Motomura K, Kato M, Tanaka T, Takaesu Y Psychiatry Clin Neurosci. 2024; 78(11):633-645.
PMID: 39194164 PMC: 11804931. DOI: 10.1111/pcn.13724.
Wilson C, Carpenter J, Nichles A, Zmicerevska N, Song Y, McHugh C BMJ Open. 2023; 13(2):e064682.
PMID: 36810174 PMC: 9945047. DOI: 10.1136/bmjopen-2022-064682.
Wu H, Dai G, Aizezi M, Tang J, Zou K, Wu Y BMC Psychiatry. 2022; 22(1):639.
PMID: 36221050 PMC: 9552355. DOI: 10.1186/s12888-022-04285-4.
Bradley T, Campbell E, Dray J, Bartlem K, Wye P, Hanly G Syst Rev. 2022; 11(1):198.
PMID: 36085250 PMC: 9462072. DOI: 10.1186/s13643-022-02067-3.